Favipiravir for COVID-19 in a Patient on Hemodialysis.

Hirai, Daisuke; Yamashita, Daisuke; Seta, Koichi

Hirai, Daisuke; Yamashita, Daisuke; Seta, Koichi.

Hirai D; Departments of Nephrology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan. Electronic address: hirai.d.aisuke610@gmail.com.
Yamashita D; Departments of Pharmacy, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Seta K; Departments of Pharmacy, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Am J Kidney Dis ; 77(1): 153-154, 2021 01.

Article in English | MEDLINE | ID: covidwho-807928

Subject(s)

Amides/therapeutic use; Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Pyrazines/therapeutic use; Renal Dialysis/trends; Aged; Amides/blood; Antiviral Agents/blood; COVID-19/blood; Humans; Male; Pyrazines/blood

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pyrazines / Renal Dialysis / Amides / COVID-19 Drug Treatment Type of study: Case report Limits: Aged / Humans / Male Language: English Journal: Am J Kidney Dis Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google